Entrada Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Entrada Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $-0.35 | $-0.73 | 52.0 % |
Jun 2024 | 2024-08-13 | $1.55 | $0.14 | 1007.1 % |
Mar 2024 | 2024-05-07 | $0.68 | $-0.59 | 215.3 % |
Dec 2023 | 2024-03-13 | $-0.29 | $-0.17 | -70.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $19.57M | $12.32M | 58.9 % |
Jun 2024 | 2024-08-13 | $94.69M | $46.07M | 105.5 % |
Mar 2024 | 2024-05-07 | $59.12M | $14.98M | 294.7 % |
Dec 2023 | 2024-03-13 | $41.85M | $23.69M | 76.6 % |
Entrada Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3.
Entrada Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was $-0.35, which beat the estimate of $-0.73.
Entrada Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.